Ascendis Pharma Oncology Division A/S

City:

Hellerup

Country:

Denmark

Published Applications:

Last publication date:

2023-06-29

Patent Grants:

Last grant date:

2024-01-23

Top Inventors for applications by Ascendis Pharma Oncology Division A/S

These are the the leading inventors for applications assigned to Ascendis Pharma Oncology Division A/S:

Nicola Bisek 2 Heidelberg, Germany
Matiss MALECKIS 2 Hellerup, Denmark
Nina GUNNARSSON 2 Hellerup, Denmark
David B. ROSEN 2 Palo Alto, CA United States

Thomas Knappe 1 Heidelberg, Germany
Harald Rau 1 Heidelberg, Denmark
Samuel Weisbrod 1 Heidelberg, Germany
Kennett Sprogøe 1 Hellerup, Denmark

Sebastian STARK 1 Heidelberg, Germany
Kennett SPROGØE 1 Hellerup, Denmark
Torben LESSMANN 1 Heidelberg, Germany
Harald Rau 1 Heldelberg, Denmark

Tobias Voigt 1 Heidelberg, Germany
Burkhardt LAUFER 1 Heidelberg, Germany
Yang YANG-MALTEN 1 Hellerup, Denmark
Burkhardt Laifer 1 Heidelberg, Germany

Recent patent applications by Ascendis Pharma Oncology Division A/S

Ascendis Pharma Oncology Division A/S based in Hellerup, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-06-29 ✅ Patent 11,879,001 granted on 2024-01-23

US20230201355A1

Human necessities

Conjugate comprising an IL-2 moiety

#2 | 2023-06-08 ✅ Patent 12,428,461 granted on 2025-09-30

US20230174605A1

Chemistry; metallurgy

IL-2 SEQUENCES AND USES THEREOF

#3 | 2022-03-03

US20220062273A1

Human necessities

CONJUGATES OF PATTERN RECOGNITION RECEPTOR AGONISTS

#4 | 2021-01-28 ✅ Patent 12,565,525 granted on 2026-03-03

US20210024602A1

Chemistry; metallurgy

IL-2 Conjugates

Also check out ASCENDIS PHARMA ONCOLOGY DIVISION A/S's (Hellerup, Denmark) applicant profile with 4 patent applications submitted.

AssigneeID:

306822 ⎘